Photo by Ryan Remiorz (ZUMA/Scanpix).
US biotech company Moderna Inc., one of the world’s leading producers of vaccines against COVID-19, suffered a loss of more than 1 billion in the first quarter of the year due to a sharp drop in demand. USD loss, hair loss in 10 times.
According to the company’s statement, the net loss in the first three months of the year amounted to 1.18 billion. USD 79 million compared to USD in net profit year-on-year, after sales revenue decreased from 1.86 billion up to 167 million USD.
Despite this, the company, which specializes in RNA vaccines for the respiratory tract disease, continues to forecast an estimated $4 billion. USD sales revenue in 2024
Moderna’s market value has decreased by 12% since the beginning of the year to 42.7 billion. USD.
[{“title”:”Moderna pirmkart met ketvirt ubaig pelningai”,”url”:”https://vz.lt/pramone/2021/05/06/moderna-pirmakart-metu-ketvirti-uzbaige-pelningai”,”category”:”ARTICLE”,”profiles”:[1014,1020,1067,1669]},{“title”:”Study: Modern vaccine creates twice as many antibodies as Pfizer”,”url”:”https://vz.lt/verslo-aplinka/2021/08/31/tyrimas-moderna-vakcina-sukuria -twice-more-antiques-than-pfizer”,”category”:”ARTICLE”,”profiles”:[1057,1067,1633,2039]},{“title”:”Moderna income grew 12 times per year”,”url”:”https://vz.lt/pramone/2022/02/25/moderna-pajamos-per-metus-augo-12- together”,”category”:”ARTICLE”,”profiles”:[1020,1067,2039]}]
It is prohibited to reproduce the information of the news agency BNS in public information media and on Internet websites without the consent of UAB “BNS”.
Select the companies and topics you are interested in and we will inform you in a personal newsletter as soon as they are mentioned in Business, Sodra, Registry Center, etc. in altos.
Topic Industry
Tags: Modernas firstquarter revenue fell times
